Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma
Junfang Ji(Shaoxing University), Xin Wei Wang(Ministry of Education of the People's Republic of China), Takahiro Uenishi(Osaka City University), Marshonna Forgues(Genesis Foundation), Zhao–You Tang(Hebei Agricultural University), Shijun Fu(Novartis (China)), Shoji Kubo(Osaka Metropolitan University), Zhipeng Yu(Sichuan University), Jia Fan(Nanjing Tech University), Jian Zhou(Fudan University), Hongguang Zhu(Qingdao University), Kenichi Wakasa(Osaka City University), Lei Yu(Taiyuan Central Hospital), Jason Jin, Hui‐Chuan Sun(Fudan University)
Cited by 28
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
GADD45 induction of a G <sub>2</sub> /M cell cycle checkpoint
|Proceedings of the National Academy of Sciences|1999|621